Particularly, since amyloid-induced neurotoxicity can depend on CD36/TLR4/TLR6-mediated inflammatory pathways, chronic inflammation induced by TREM2 mutations can directly increase neurotoxicity, which may accelerate AD-related neurodegeneration. This evidence concerns the gene TREM2 and amyloidosis.